Yu.S. Krivosheev

Yu.S. Krivosheev

Auto-generated profile, based on publicly available information

Yu.S. Krivosheev

Regional Clinical Cardiology Dispensary

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 May 2021 in Russian Journal of Cardiology
Verified
Journal Article
Open access
PDF file
Denis LosikDenis Losik
Denis Losik
SKS. N. Kozlova
S. N. Kozlova
YKYu. S. Krivosheev
Yu. S. Krivosheev
APAndrey Ponomarenko
Andrey Ponomarenko
DPD. N. Ponomarev
D. N. Ponomarev
AKA. O. Konradi
A. O. Konradi
Aim. To evaluate the relationship between the clinical decision support system use (CDSS) and adherence to clinical guidelines.Materials and methods. Medical records of 300 patients with atrial fibrillation and hypertension from the electronic medical database of the Almazov National Medical Research Center were analyzed. Demographic and clinical data, as well as information on anticoagulant, antiarrhythmic and antihypertensive prescriptions were analyzed. The primary endpoint was adherence of prescribed treatment to current clinical guidelines for each of the three therapies. Firstly, a group of independent clinical experts assessed primary endpoint for retrospective prescriptions. Secondly, new prescriptions were simulated by another group of clinical experts using CDSS and blinded to previous therapy. Primary endpoint at the second step was analysed by independent experts. We compared adherence to relevant clinical guidelines with and without use of CDSS. Additionally, we analyzed predictors of failing to meet the current recommendations in the retrospective records.Results. Out of 300 patients, only 291 (97%) had all characteristics and were included in the analysis. In 26 patients (18%), all three treatment strategies were in accordance with current clinical guidelines. Anticoagulant therapy was adherent to the guidelines in 92% of cases. Experts who used CDSS were 15% (95% confidence interval [CI], 10-21%) more likely to prescribe novel oral anticoagulants and 14% (95% CI, 10-19%) less likely to prescribe warfarin compared to baseline. Antiarrhythmic therapy was adherent to the guidelines in 69% of cases. When the CDSS platform was applied, experts were 14% (95% CI 4-19%) more likely to prefer antiarrhythmic drug (AAD) monotherapy and 32% (95% CI 26-37%) more often prescribed radiofrequency ablation (RFA) of left atrium. At baseline, antihypertensive therapy combinations were adherent clinical guidelines in 28% of cases. The use of the CDSS platform by experts was significantly associated with an increase in the frequency of prescribing dual and triple antihypertensive therapy.Conclusion. CDSS use is associated with improved adherence to current clinical guidelines. Prospective randomized trials are needed to evaluate the CDSS effectiveness in the prevention of cardiovascular events.

24 April 2023 in Russian Cardiology Bulletin
Verified
Journal Article
Closed access
APAndrey Ponomarenko
Andrey Ponomarenko
YKY.S. Krivosheev
Y.S. Krivosheev
IMI.L. Mikheenko
I.L. Mikheenko
ESE.V. Sorokin
E.V. Sorokin
OSO.V. Sapelnikov
O.V. Sapelnikov
Denis LosikDenis Losik
Denis Losik
Применение сервиса поддержки принятия врачебных решений (СППВР) для работы с большим количеством цифровых данных, таких как электронные медицинские карты (ЭМК), может сыграть важную роль в улучшении качества оказываемой медицинской помощи. ЦЕЛЬ ИССЛЕДОВАНИЯ Оценить перспективы проведения автоматизированного анализа при помощи СППВР соответствия критериев отбора пациентов для катетерной аблации по поводу фибрилляции предсердий (ФП) данным в электронных медицинских картах (ЭМК) среди карт в группах повторной и первичной процедур в реальной клинической практике крупных медицинских центров. МАТЕРИАЛ И МЕТОДЫ Проанализированы ЭМК 232 пациентов, направленных на катетерную аблацию легочных вен по поводу ФП. Основными предикторами рецидива ФП при автоматическом анализе СППВР считались следующие характеристики: возраст, индекс массы тела (ИМТ) и продольный размер левого предсердия (ЛП) по эхокардиографическим данным. РЕЗУЛЬТАТЫ У 137 (59,1%) пациентов, направленных на катетерную аблацию, не имелось предикторов рецидива ФП. Аблация в анамнезе была у 141 (60,8%) пациента. Риск рецидива аритмии выявлен у 49,5% пациентов, направленных на первичную процедуру, и у 36,2% пациентов из группы повторной аблации. ЭМК с прогнозируемым риском рецидива ФП по возрастному критерию составили 14,3% в группе первичной аблации и 5,7% в группе повторной аблации (p=0,026). Доля ЭМК пациентов с прогнозируемым риском рецидива ФП по критерию ИМТ составила 17,6% в группе первичной аблации и 17,7% в группе повторной аблации (p=0,977). Увеличенный размер ЛП был выявлен в качестве прогнозируемого условия рецидива ФП в 26,4% случаев в группе первичной аблации и 18,4% в группе повторной аблации (p=0,152). ЗАКЛЮЧЕНИЕ Среди пациентов с показаниями для катетерной аблации с целью устранения фибрилляции предсердий существенную долю составляют лица с рецидивами аритмии после предыдущих катетерных вмешательств. Отбор пациентов на повторные вмешательства проводится более тщательно. Необходимы современные цифровые инструменты для отбора пациентов на катетерные методы лечения, что может снизить количество повторных процедур и рецидивов ФП.

17 August 2025 in Cardiovascular Therapy and Prevention
Verified
Journal Article
Open access
PDF file
STS. N. Tereshchenko
S. N. Tereshchenko
IZI. V. Zhirov
I. V. Zhirov
ASA. M. Shangina
A. M. Shangina
FPF. N. Paleev
F. N. Paleev
SBSergey Boytsov
Sergey Boytsov
VPV. A. Petrakovskaia
V. A. Petrakovskaia
Aim . To assess the impact of a clinical decision support system (CDSS) aimed at increasing physician compliance with clinical guidelines on heart failure (HF) in real-world practice in order to improve the effectiveness of managing this category of patients and clinical outcomes in pilot Russian regions. Material and methods . As part of the retrospective multicenter study SPHERA-HF, data of electronic health records from 49 medical facilities in three Russia regions were analyzed. The study participants were divided into inpatient and outpatient cohorts. The main inclusion criterion was a history of HF diagnosis. The features of patient management in real-world practice were studied before and after the implementation of the CDSS. Results. The study included 66166 patients. After CDSS imple neprilysin inhibitors in patients with HF with reduced ejection fraction increased in the in-hospital cohort from 32,9% to 52,3% (p<0,05); in the outpatient cohort from 24,2% to 45,3% (p<0,05). There was an increase in the prescription rate of quadruple therapy at discharge in the inhospital cohort from 22,3% to 32,6% (p<0,05); at the initiation visit in the outpatient cohort from 24,6% to 42,9% (p<0,05). There was a decrease in the number of rehospitalizations for cardiovascular diseases in the inhospital cohort from 26,9% to 20,1% (p<0,05). Conclusion. The study results indicate a positive impact of CDSS introduction on managing patients with HF.

5 December 2023 in Kardiologiia
Verified
Journal Article
Open access
PDF file
KBK. S. Benimetskaya
K. S. Benimetskaya
SPS. I. Provatorov
S. I. Provatorov
Marat EzhovMarat Ezhov
Marat Ezhov
YKY. S. Krivosheev
Y. S. Krivosheev
AGA. D. Gavrilko
A. D. Gavrilko
Denis LosikDenis Losik
Denis Losik
Aim To evaluate prescription of lipid-lowering and antithrombotic therapy in clinical practice and to compare differences in recommendations using the clinical decision support service (CDSS). Material and methods Electronic medical records (EMR) of 300 patients from the Chazov National Medical Research Center of Cardiology, as well as from medical organizations controlled by the Department of Health of the Lipetsk Region and the Ministry of Health of the Voronezh Region, were analyzed for the period of August - December 2022, during the pilot implementation of CDSS. Retrospective information about the prescription of lipid-lowering and antithrombotic therapy from the EMR was compared with the CDSS guidelines under the expert supervision based on digitized clinical and laboratory profiles of patients. The study primary endpoint was a change in the initially prescribed lipid-lowering and / or antithrombotic therapy as per CDSS guidelines. Results Overall 292 patients were included in the final analysis; 46 (15.7 %) were from the primary prevention group and 246 (84.3 %) from the secondary prevention group. In group 1, the lipid-lowering therapy recommended by the CDSS differed by 50 % (p<0.001) from the baseline therapy recorded in the EMR. In the secondary prevention group, 78.9 % (p<0.001) differences were found in the lipid-lowering therapy recommended in the CDSS guidelines compared to the prescriptions in the EMR. In 76.8 % (p<0.001) of patients, antithrombotic therapy was significantly different from the baseline therapy in the EMR. Conclusion The use of CDSS may improve the practice of choosing lipid-lowering and antithrombotic therapy for prevention of cardiovascular complications.

8 June 2023 in Cardiovascular Therapy and Prevention
Verified
Journal Article
Open access
PDF file
NIN. N. Ilov
N. N. Ilov
SBS. A. Boitsov
S. A. Boitsov
YKYu. S. Krivosheev
Yu. S. Krivosheev
ANA. A. Nechepurenko
A. A. Nechepurenko
Aim. To evaluate the impact of cardiac resynchronization therapy (CRT) on the risk of sustained ventricular tachyarrhythmias (VT) in patients with heart failure (HF) with a implantable cardioverter-defibrillator (ICD) for the primary prevention of sudden cardiac death.Material and methods. This single-center prospective clinical study included 470 patients (men, 84%) with HF at the age of 57 (51-62) years with a left ventricular ejection fraction (LVEF) of 29 (25-33)%. There were following exclusion criteria: indications for cardiac surgery, known channelopathies, previously registered VT. Depending on intraventricular conduction disorders, dual-chamber ICDs (42%) or CRT-D (58%) were implanted. After ICD implantation, patients were followed up for 24 months to register the end point — a first-time sustained paroxysm of VT detected by the ICD. A positive response to CRT was established in the case of an increase in LVEF by ≥5% of the initial level.Results. A total of 388 patients underwent full postoperative follow-up. The studied arrhythmic endpoint occurred on average 21 (0,6) months after implantation in 104 patients (27%) with higher frequency in the ICD group. However, the differences in the VT rate in the study groups were statistically unreliable (30% in the ICD group versus 24% in the CRT-D group, p=0,142). It was found that the VT rate was reliably lower in CRT-responders (118 patients, 53%): 15% compared to 32% in the group of inefficient CRT. A 5% increase in the LFEF reduced the probability of VT occurrence by 3 times (odds ratio [OR]=0,34; 95% of CI: 0,13-0,86; p=002). Significant modification of arrhythmic risk was verified by increasing LFEF to 36-40% (OR=0,72; 95% CI: 0,63-0,82; p=0,04).Conclusion. The results obtained indicate that effective CRT has the potential to modify arrhythmic risk in patients with HF, especially with an increase in LVEF to the level of 36-40%.

29 December 2022 in Patologiya krovoobrashcheniya i kardiokhirurgiya
Verified
Journal Article
Open access
PDF file
DBD.I. Bashta
D.I. Bashta
LVL.I. Vilenskiy
L.I. Vilenskiy
YKYu.S. Krivosheev
Yu.S. Krivosheev
ASA.A. Simonyan
A.A. Simonyan
ARAlexander Romanov
Alexander Romanov
Background: Currently, intra-arterial radiofrequency renal denervation is an only interventional treatment for resistant hypertension. However, available data are controversial since this method does not provide the long-term hypotensive effect.Objective: To compare the safety and efficacy of laparoscopic mechanical renal denervation and laparoscopic combined renal denervation using a radiofrequency clamp.Methods: Thirty sheep weighing 93.00 ± 3.72 kg were divided into two groups for mechanical laparoscopic renal denervation (group I, n = 15) and combined laparoscopic renal denervation with a radiofrequency clamp (group II, n = 15). The observation period lasted for six months. We assessed the following parameters: blood pressure (BP) in response to high-frequency electric stimulation from the lumen of the vessel, creatinine and uric acid levels, iatrogenic damage to the renal arteries based on angiography findings, and destruction of nerve fibers based on histological findings.Results: All the animals survived throughout the observation period. Creatinine and uric acid levels were within the normal ranges. Renal angiography did not reveal any iatrogenic stenosis. After six months, we found some BP response (elevated systolic BP ∆66.73 ± 6.63 mm Hg [p < 0.001], elevated diastolic BP ∆47.27 ± 5.98 mm Hg [p < 0.001]) to high-frequency electric stimulation in group I and no hypertensive response in group II. After six months, the animals were withdrawn for further histological assessment. Histology revealed complete destruction of the nerve fiber (demyelination) in group II and vacuolized swollen nerve fibers without any signs of demyelination in group I.Conclusion: Laparoscopic combined renal denervation is a safe and efficacious method with a stable hypotensive effect after six months in an animal model as compared to laparoscopic mechanical renal denervation. Received 30 March 2022. Revised 5 December 2022. Accepted 9 December 2022. Funding: The study did not have sponsorship. Conflict of interest: Authors declare no conflict of interest. Contribution of the authorsConception and study design: D.I. Bashta, L.I. Vilenskiy, A.B. RomanovData collection and analysis: D.I. Bashta, Yu.S. Krivosheev, A.A. SimonyanStatistical analysis: D.I. Bashta, Yu.S. KrivosheevDrafting the article: D.I. Bashta, Yu.S. Krivosheev Critical revision of the article: L.I. Vilenskiy, Yu.S. Krivosheev, A.B. Romanov Final approval of the version to be published: D.I. Bashta, L.I. Vilenskiy, Yu.S. Krivosheev, A.A. Simonyan, A.B. Romanov